hyperlipidemia_Apc<tm2Tno>/Apc<+>

http://metadb.riken.jp/0001548IC57BL6JApctm2TnoApcApctm2TnoApc

hyperlipidemia_Apc<tm2Tno>/Apc<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• adenomatosis polyposis coli
  http://metadb.riken.jp/db/mgi_rdf/MGI:88039

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Apc<tm2Tno>/Apc<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Apc<tm2Tno>|Apc<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• hyperlipidemia
  http://purl.obolibrary.org/obo/MP_0001548

文献

http://purl.org/net/cito/citesAsAuthority

• Naoko. Niho, et.al., Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands., Cancer research, 2003, 63
  http://rdf.ncbi.nlm.nih.gov/pubmed/14522940